Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris

2004 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris​
Haenssle, H. A.; Bertsch, H.-P.; Emmert, S.; Wolf, C. & Zutt, M.​ (2004) 
Clinical and Experimental Dermatology29(3) pp. 244​-246​.​ DOI: https://doi.org/10.1111/j.1365-2230.2004.01468.x 

Documents & Media

License

GRO License GRO License

Details

Authors
Haenssle, Holger Andreas; Bertsch, Hans-Peter; Emmert, Steffen; Wolf, C.; Zutt, Markus
Abstract
Pityriasis rubra pilaris (PRP) is a rare papulosquamous skin disease of unknown aetiology that has been categorized into five clinical types based on age at onset, cutaneous features and prognosis. We present a patient with chronic exanthematic type II atypical adult PRP, whose skin status was significantly improved with monthly extracorporeal photochemotherapy (ECP). Various therapeutic regimens including narrow-band UV-B, bath PUVA therapy, systemic fumaric acid esters and systemic cyclosporin had failed. Oral retinoids could not be administered due to a type IIa hyperlipoproteinemia with profound hepatic steatosis and elevated liver transaminases. The observed clinical benefit may encourage future clinical studies analysing the effectiveness of ECP in otherwise unresponsive cases of type II PRP.
Issue Date
2004
Status
published
Publisher
Blackwell Publishing Ltd
Journal
Clinical and Experimental Dermatology 
ISSN
0307-6938

Reference

Citations


Social Media